HALOZYME THERAPEUTICS, INC. - Common Stock (HALO)
CUSIP: 40637H109
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 123,650,000
- Total 13F shares
- 116,352,424
- Share change
- -3,518,085
- Total reported value
- $6,053,937,391
- Put/Call ratio
- 95%
- Price per share
- $52.02
- Number of holders
- 541
- Value change
- -$203,145,554
- Number of buys
- 261
- Number of sells
- 295
Quarterly Holders Quick Answers
What is CUSIP 40637H109?
CUSIP 40637H109 identifies HALO - HALOZYME THERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 40637H109:
Top shareholders of HALO - HALOZYME THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
|
Company |
10%
from 13D/G
|
17,092,111
|
$1,090,647,602 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
10%
|
12,831,503
|
$818,778,208 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
13D/G
|
Company · STATE STREET CORPORATION |
4.9%
from 13D/G
|
6,053,007
|
$386,242,377 | — | 31 Mar 2025 | |
| Invesco Ltd. |
13F
|
Company |
3.1%
|
3,894,297
|
$248,495,091 | — | 31 Mar 2025 | |
| SNYDER CAPITAL MANAGEMENT L P |
13F
|
Company |
3%
|
3,674,302
|
$234,457,211 | — | 31 Mar 2025 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
2.6%
|
3,215,109
|
$205,156,105 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.6%
|
3,169,240
|
$202,273,720 | — | 31 Mar 2025 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
2.2%
|
2,674,273
|
$170,645,000 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
2%
|
2,474,825
|
$157,918,583 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.9%
|
2,314,062
|
$147,660,295 | — | 31 Mar 2025 | |
| CONGRESS ASSET MANAGEMENT CO |
13F
|
Company |
1.7%
|
2,132,707
|
$136,088,034 | — | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.6%
|
2,029,160
|
$129,477,555 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.6%
|
1,931,474
|
$123,247,460 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
1.4%
|
1,748,851
|
$111,594,182 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.4%
|
1,740,281
|
$111,047,331 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.2%
|
1,518,915
|
$96,921,966 | — | 31 Mar 2025 | |
| GW&K Investment Management, LLC |
13F
|
Company |
1.2%
|
1,464,891
|
$93,475,000 | — | 31 Mar 2025 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
1.2%
|
1,451,842
|
$92,642,038 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
1.2%
|
1,428,797
|
$91,171,537 | — | 31 Mar 2025 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
1.1%
|
1,363,439
|
$87,001,043 | — | 31 Mar 2025 | |
| Stephens Investment Management Group LLC |
13F
|
Company |
1.1%
|
1,336,974
|
$85,312,311 | — | 31 Mar 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.96%
|
1,186,730
|
$75,726,000 | — | 31 Mar 2025 | |
| Artisan Partners Limited Partnership |
13F
|
Company |
0.92%
|
1,138,651
|
$72,657,320 | — | 31 Mar 2025 | |
| FULLER & THALER ASSET MANAGEMENT, INC. |
13F
|
Company |
0.91%
|
1,130,019
|
$72,106,520 | — | 31 Mar 2025 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
0.9%
|
1,115,507
|
$71,180,502 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.79%
|
982,000
|
$62,661,440 | — | 31 Mar 2025 | |
| CAISSE DE DEPOT ET PLACEMENT DU QUEBEC |
13F
|
Company |
0.74%
|
910,169
|
$58,077,882 | — | 31 Mar 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.72%
|
895,412
|
$57,136,283 | — | 31 Mar 2025 | |
| LSV ASSET MANAGEMENT |
13F
|
Company |
0.72%
|
895,191
|
$57,122,000 | — | 31 Mar 2025 | |
| Boston Trust Walden Corp |
13F
|
Company |
0.7%
|
866,872
|
$55,315,102 | — | 31 Mar 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.67%
|
832,532
|
$53,123,867 | — | 31 Mar 2025 | |
| Epoch Investment Partners, Inc. |
13F
|
Company |
0.67%
|
827,247
|
$52,786,631 | — | 31 Mar 2025 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.65%
|
803,694
|
$51,283,714 | — | 31 Mar 2025 | |
| Capital World Investors |
13F
|
Company |
0.61%
|
748,230
|
$47,744,556 | — | 31 Mar 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.58%
|
714,727
|
$45,631,662 | — | 31 Mar 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.55%
|
681,252
|
$43,477,125 | — | 31 Mar 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.52%
|
646,028
|
$41,223,047 | — | 31 Mar 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.5%
|
623,465
|
$39,783,287 | — | 31 Mar 2025 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.5%
|
623,020
|
$39,754,906 | — | 31 Mar 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.5%
|
619,562
|
$39,534,252 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.47%
|
582,877
|
$37,193,382 | — | 31 Mar 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.44%
|
540,849
|
$34,512,000 | — | 31 Mar 2025 | |
| GLENMEDE TRUST CO NA |
13F
|
Company |
0.4%
|
499,029
|
$31,843,040 | — | 31 Mar 2025 | |
| ROYAL LONDON ASSET MANAGEMENT LTD |
13F
|
Company |
0.4%
|
495,676
|
$31,629,085 | — | 31 Mar 2025 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.38%
|
474,453
|
$30,274,846 | — | 31 Mar 2025 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.38%
|
470,183
|
$30,002,378 | — | 31 Mar 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.37%
|
463,608
|
$29,582,826 | — | 31 Mar 2025 | |
| Neuberger Berman Group LLC |
13F
|
Company |
0.37%
|
462,527
|
$29,513,848 | — | 31 Mar 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.36%
|
442,757
|
$28,252,324 | — | 31 Mar 2025 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.34%
|
424,711
|
$27,100,809 | — | 31 Mar 2025 |
Institutional Holders of HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) as of Q2 2025
As of 30 Jun 2025,
HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) was held by
541 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
116,352,424 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, STATE STREET CORP, Invesco Ltd., SNYDER CAPITAL MANAGEMENT L P, ARROWSTREET CAPITAL, LIMITED PARTNERSHIP, ALLIANCEBERNSTEIN L.P., GEODE CAPITAL MANAGEMENT, LLC, MACQUARIE GROUP LTD, and BANK OF AMERICA CORP /DE/.
This page lists
542
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
543
Q2 2025 holders
541
Holder diff
-2
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.